-
Mashup Score: 0OncLive - Clinical Oncology News, Cancer Expert Insights - 1 hour(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0TAB-Follicular Lymphoma - 3 hour(s) ago
Advancements in FL treatment, including BTK inhibitors and CAR T-cell therapies, offer new hope for relapsed or refractory cases.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Advancements in FL treatment, including BTK inhibitors and CAR T-cell therapies, offer new hope for relapsed or refractory cases. @gotoPER #CFS24 #gotoPER https://t.co/XEvRUP74Xi
-
-
Mashup Score: 1
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet-
A recent study has shown that combining amivantamab with lazertinib significantly reduces the emergence of #EGFR and #MET resistance mutations in patients with EGFR-mutant #NSCLC. https://t.co/6OTqiqBsL2 https://t.co/mM5D2FPg2J
-
-
Mashup Score: 0OncLive - Clinical Oncology News, Cancer Expert Insights - 5 hour(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Today we share this week's #TestimonialTuesday! See what Dr Tawbi, of @MDAndersonNews, expert oncologist, had to say about #OncLive, and check back to our website to see timely updates from the oncology professionals themselves! #DoYouKnowOncLive https://t.co/LDL198hPGw https://t.co/tJebJaHtsE
-
-
Mashup Score: 0ERBB2-Low Expression in Endometrial Cancer - 6 hour(s) ago
This study reanalyzes epidermal growth factor receptor 2 (ERBB2) data from a previous study to characterize patient subgroups with ERBB2-low tumors.
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet-
This study reanalyzes epidermal growth factor receptor 2 (ERBB2) data from a previous study to characterize patient subgroups with ERBB2-low tumors. https://t.co/F7CVaZePhW https://t.co/oTuKkFu7vy
-
-
Mashup Score: 1Cancer of the Lung and Bronchus - Cancer Stat Facts - 8 hour(s) ago
Lung and Bronchus Cancer statistics
Source: seer.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
Rates of new #LungCancer cases are higher for men than women. The rate of new cases is higher than average for Non-Hispanic Black men and Non-Hispanic White men and women. Visit our Cancer Stat Facts sheet to learn more: https://t.co/BVqvN4e1pm #LCSM https://t.co/rku2X5EQnz
-
-
Mashup Score: 0OncLive - Clinical Oncology News, Cancer Expert Insights - 10 hour(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Today we share this week's #TestimonialTuesday! See what Dr Tawbi, of @MDAndersonNews, expert oncologist, had to say about #OncLive, and check back to our website to see timely updates from the oncology professionals themselves! #DoYouKnowOncLive https://t.co/LDL198hPGw https://t.co/tJebJaHtsE
-
-
Mashup Score: 15Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer - 14 hour(s) ago
This randomized clinical trial evaluates the efficacy and safety of first-line toripalimab vs placebo plus etoposide and platinum-based chemotherapy for treating patients with extensive-stage small cell lung cancer.
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet-
Most viewed in the last 7 days from @JAMAOnc: Adding toripalimab to first-line chemotherapy demonstrated significant improvements in progression-free survival and OS for patients with extensive-stage small cell lung cancer. https://t.co/Shx94lIYTM https://t.co/L2gPNzLrjG
-
-
Mashup Score: 1
During a Case-Based Roundtable® event, Kristen Pettit, MD, moderated a discussion on which disease features of myelofibrosis are most challenging and when to use JAK inhibitors in the first article of a 2-part series.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet-
Kristen Pettit, MD, moderated a discussion on which disease features of #myelofibrosis are most challenging and when to use JAK inhibitors. #MPNSM | @kristenpettitmd https://t.co/vNqvXN2bNh
-
-
Mashup Score: 6Conversations on Cancer - 1 day(s) ago
Conversations on Cancer
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet-
Conversations on Cancer: Making Cancer Personal is a dynamic OCE public panel discussion series examining cancer-related social issues with inclusive and diverse panel members from the US & within the FDA. Past event videos posted here ⤵️ https://t.co/iFZ82acpbT
-
Today we share this week's #TestimonialTuesday! See what Dr Tawbi, of @MDAndersonNews, expert oncologist, had to say about #OncLive, and check back to our website to see timely updates from the oncology professionals themselves! #DoYouKnowOncLive https://t.co/LDL198hPGw https://t.co/tJebJaHtsE